<?xml version="1.0" encoding="UTF-8"?>
<ref id="B7">
 <label>7.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Halamoda-Kenzaoui</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Baconnier</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Bastogne</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Bazile</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Boisseau</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Borchard</surname>
    <given-names>G</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Bridging communities in the field of nanomedicine</article-title>. 
  <source>Regul Toxicol Pharmacol</source>. (
  <year>2019</year>) 
  <volume>106</volume>:
  <fpage>187</fpage>â€“
  <lpage>96</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.yrtph.2019.04.011</pub-id>
  <?supplied-pmid 31051191?>
  <pub-id pub-id-type="pmid">31051191</pub-id>
 </mixed-citation>
</ref>
